Skip to main content
NCBI home page
Archives of Disease in Childhood. Fetal and Neonatal Edition logoLink to Archives of Disease in Childhood. Fetal and Neonatal Edition
. 1997 Sep;77(2):F100–F104. doi: 10.1136/fn.77.2.f100

Developmental pattern of fetal growth hormone, insulin-like growth factor I, growth hormone binding protein and insulin-like growth factor binding protein-3

P Pirazzoli, E Cacciari, R De Iasio, M Pittalis, P Dallacasa, S Zucchini, S Gualandi, S Salardi, C David, S Boschi
PMCID: PMC1720686  PMID: 9377129

Abstract

AIMS—To evaluate the developmental pattern of fetal growth hormone (GH), insulin-like growth factor I (IGF-I), GH binding protein (GHBP) and IGF binding protein-3 (IGF-3); to determine the implications for fetal growth.
METHODS—Serum GH, IGF-I, GHBP and IGFBP-3 were measured in 53 fetuses, 41 aged 20-26 weeks (group A) and 12 aged 31-38 weeks (group B). Fetal blood samples were obtained by direct puncture of the umbilical vein in utero. Fetal blood samples were taken to rule out β thalassaemia, chromosome alterations, mother to fetus transmissible infections, and for maternal rhesus factor. GHBP was determined by gel filtration chromatography of serum incubated overnight with 125I-GH. GH, IGF-I and IGFBP-3 were determined by radioimmunoassay.
RESULTS—Fetal serum GH concentrations in group A (median 29 µg/l, range 11-92) were significantly higher (P<0.01) than those of group B (median 16.7 µg/l, range 4.5-29). IGF-I in group A (median 20 µg/l, range 4.1-53.3) was significantly lower (P<0.01) than in group B (median 75.2 µg/l, range 27.8-122.3). Similarly, IGFBP-3 concentrations in group A (median 950 µg/l, range 580-1260) were significantly lower than those of group B (median 1920 µg/l, range 1070-1770). There was no significant difference between GHBP values in group A (median 8.6%, range 6.6-12.6) and group B (median 8.3%, range 6-14.3). Gestational age correlated positively with IGF-I concentrations (P<0.0001) and IGFBP-3 (P<0.0001) and negatively with GH (P<0.0001). GHBP values did not correlate with gestational age. Multiple regression analysis showed a negative correlation between GH:IGF-I ratio and fetal growth indices
CONCLUSIONS—The simultaneous evaluation of fetal GH, IGF-I, IGFBP-3 and GHBP suggests that the GH-IGF-I axis might already be functional in utero. The progressive improvement in the efficiency of this axis in the last part of gestation does not seem to be due to an increase in GH receptors.

 Keywords: insulin-like growth factor I; IGF-binding protein; growth hormone-binding protein; somatotropin

Full Text

The Full Text of this article is available as a PDF (125.5 KB).

Figure 1  .

Figure 1  

Open in a new tab

Correlation between GH values and gestational age.

Figure 2  .

Figure 2  

Open in a new tab

Correlation between IGF-I values and gestational age.

Figure 3  .

Figure 3  

Open in a new tab

Correlation between IGFBP-3 values and gestational age.

Figure 4  .

Figure 4  

Open in a new tab

Correlation between GHBP values and gestational age.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bang P., Westgren M., Schwander J., Blum W. F., Rosenfeld R. G., Stangenberg M. Ontogeny of insulin-like growth factor-binding protein-1, -2, and -3: quantitative measurements by radioimmunoassay in human fetal serum. Pediatr Res. 1994 Oct;36(4):528–536. doi: 10.1203/00006450-199410000-00020. [DOI] [PubMed] [Google Scholar]
  2. Barrios V., Argente J., Pozo J., Hervás F., Muñoz M. T., Sánchez J. I., Hernández M. Insulin-like growth factor I, insulin-like growth factor binding proteins, and growth hormone binding protein in Spanish premature and full-term newborns. Horm Res. 1996;46(3):130–137. doi: 10.1159/000185009. [DOI] [PubMed] [Google Scholar]
  3. Bauer M. K., Breier B. H., Harding J. E., Veldhuis J. D., Gluckman P. D. The fetal somatotropic axis during long term maternal undernutrition in sheep: evidence for nutritional regulation in utero. Endocrinology. 1995 Mar;136(3):1250–1257. doi: 10.1210/endo.136.3.7867579. [DOI] [PubMed] [Google Scholar]
  4. Bick T., Amit T., Barkey R. J., Hertz P., Youdim M. B., Hochberg Z. The interrelationship of growth hormone (GH), liver membrane GH receptor, serum GH-binding protein activity, and insulin-like growth factor I in the male rat. Endocrinology. 1990 Apr;126(4):1914–1920. doi: 10.1210/endo-126-4-1914. [DOI] [PubMed] [Google Scholar]
  5. Blum W. F., Albertsson-Wikland K., Rosberg S., Ranke M. B. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab. 1993 Jun;76(6):1610–1616. doi: 10.1210/jcem.76.6.7684744. [DOI] [PubMed] [Google Scholar]
  6. Blum W. F., Ranke M. B., Kietzmann K., Gauggel E., Zeisel H. J., Bierich J. R. A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: its use for diagnosis of GH deficiency. J Clin Endocrinol Metab. 1990 May;70(5):1292–1298. doi: 10.1210/jcem-70-5-1292. [DOI] [PubMed] [Google Scholar]
  7. Bovicelli L., Orsini L. F., Grannum P. A., Pittalis M. C., Toffoli C., Dolcini B. A new funipuncture technique: two-needle ultrasound- and needle biopsy-guided procedure. Obstet Gynecol. 1989 Mar;73(3 Pt 1):428–431. [PubMed] [Google Scholar]
  8. CORNBLATH M., PARKER M. L., REISNER S. H., FORBES A. E., DAUGHADAY W. H. SECRETION AND METABOLISM OF GROWTH HORMONE IN PREMATURE AND FULL-TERM INFANTS. J Clin Endocrinol Metab. 1965 Feb;25:209–218. doi: 10.1210/jcem-25-2-209. [DOI] [PubMed] [Google Scholar]
  9. Davenport M. L., D'Ercole A. J., Underwood L. E. Effect of maternal fasting on fetal growth, serum insulin-like growth factors (IGFs), and tissue IGF messenger ribonucleic acids. Endocrinology. 1990 Apr;126(4):2062–2067. doi: 10.1210/endo-126-4-2062. [DOI] [PubMed] [Google Scholar]
  10. Giudice L. C., de Zegher F., Gargosky S. E., Dsupin B. A., de las Fuentes L., Crystal R. A., Hintz R. L., Rosenfeld R. G. Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab. 1995 May;80(5):1548–1555. doi: 10.1210/jcem.80.5.7538146. [DOI] [PubMed] [Google Scholar]
  11. Gluckman P. D., Gunn A. J., Wray A., Cutfield W. S., Chatelain P. G., Guilbaud O., Ambler G. R., Wilton P., Albertsson-Wikland K. Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure. The International Board of the Kabi Pharmacia International Growth Study. J Pediatr. 1992 Dec;121(6):920–923. doi: 10.1016/s0022-3476(05)80342-7. [DOI] [PubMed] [Google Scholar]
  12. Hadlock F. P., Harrist R. B., Sharman R. S., Deter R. L., Park S. K. Estimation of fetal weight with the use of head, body, and femur measurements--a prospective study. Am J Obstet Gynecol. 1985 Feb 1;151(3):333–337. doi: 10.1016/0002-9378(85)90298-4. [DOI] [PubMed] [Google Scholar]
  13. Juul A., Dalgaard P., Blum W. F., Bang P., Hall K., Michaelsen K. F., Müller J., Skakkebaek N. E. Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab. 1995 Aug;80(8):2534–2542. doi: 10.1210/jcem.80.8.7543116. [DOI] [PubMed] [Google Scholar]
  14. Kaplan S. L., Grumbach M. M., Shepard T. H. The ontogenesis of human fetal hormones. I. Growth hormone and insulin. J Clin Invest. 1972 Dec;51(12):3080–3093. doi: 10.1172/JCI107135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Karlberg J., Albertsson-Wikland K. Infancy growth pattern related to growth hormone deficiency. Acta Paediatr Scand. 1988 May;77(3):385–391. doi: 10.1111/j.1651-2227.1988.tb10665.x. [DOI] [PubMed] [Google Scholar]
  16. Kim J. D., Näntö-Salonen K., Szczepankiewicz J. R., Rosenfeld R. G., Glasscock G. F. Evidence for pituitary regulation of somatic growth, insulin-like growth factors-I and -II, and their binding proteins in the fetal rat. Pediatr Res. 1993 Feb;33(2):144–151. doi: 10.1203/00006450-199302000-00012. [DOI] [PubMed] [Google Scholar]
  17. Lamson G., Giudice L. C., Rosenfeld R. G. Insulin-like growth factor binding proteins: structural and molecular relationships. Growth Factors. 1991;5(1):19–28. doi: 10.3109/08977199109000268. [DOI] [PubMed] [Google Scholar]
  18. Langford K. S., Nicolaides K. H., Jones J., Abbas A., McGregor A. M., Miell J. P. Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal, and multiple human pregnancy. J Clin Endocrinol Metab. 1995 Jan;80(1):21–27. doi: 10.1210/jcem.80.1.7530257. [DOI] [PubMed] [Google Scholar]
  19. Laron Z., Pertzelan A. Somatotrophin in antenatal and perinatal growth and development. Lancet. 1969 Mar 29;1(7596):680–681. doi: 10.1016/s0140-6736(69)92052-2. [DOI] [PubMed] [Google Scholar]
  20. Lassarre C., Hardouin S., Daffos F., Forestier F., Frankenne F., Binoux M. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res. 1991 Mar;29(3):219–225. doi: 10.1203/00006450-199103000-00001. [DOI] [PubMed] [Google Scholar]
  21. Leger J., Oury J. F., Noel M., Baron S., Benali K., Blot P., Czernichow P. Growth factors and intrauterine growth retardation. I. Serum growth hormone, insulin-like growth factor (IGF)-I, IGF-II, and IGF binding protein 3 levels in normally grown and growth-retarded human fetuses during the second half of gestation. Pediatr Res. 1996 Jul;40(1):94–100. doi: 10.1203/00006450-199607000-00017. [DOI] [PubMed] [Google Scholar]
  22. Massa G., de Zegher F., Vanderschueren-Lodeweyckx M. Serum growth hormone-binding proteins in the human fetus and infant. Pediatr Res. 1992 Jul;32(1):69–72. doi: 10.1203/00006450-199207000-00013. [DOI] [PubMed] [Google Scholar]
  23. Muaku S. M., Beauloye V., Thissen J. P., Underwood L. E., Ketelslegers J. M., Maiter D. Effects of maternal protein malnutrition on fetal growth, plasma insulin-like growth factors, insulin-like growth factor binding proteins, and liver insulin-like growth factor gene expression in the rat. Pediatr Res. 1995 Mar;37(3):334–342. doi: 10.1203/00006450-199503000-00014. [DOI] [PubMed] [Google Scholar]
  24. Nishi Y., Masuda H., Nishimura S., Kihara M., Suwa S., Tachibana K., Takeda M., Okada Y., Matsuda I. Isolated human growth hormone deficiency due to the hGH-I gene deletion with (type IA) and without (the Israeli-type) hGH antibody formation during hGH therapy. Acta Endocrinol (Copenh) 1990 Feb;122(2):267–271. doi: 10.1530/acta.0.1220267. [DOI] [PubMed] [Google Scholar]
  25. Nonoshita L. D., Wathen N. C., Dsupin B. A., Chard T., Giudice L. C. Insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and proteolyzed IGFBP-3 in embryonic cavities in early human pregnancy: their potential relevance to maternal-embryonic and fetal interactions. J Clin Endocrinol Metab. 1994 Nov;79(5):1249–1255. doi: 10.1210/jcem.79.5.7525630. [DOI] [PubMed] [Google Scholar]
  26. REID J. D. Congenital absence of the pituitary gland. J Pediatr. 1960 May;56:658–664. doi: 10.1016/s0022-3476(60)80341-1. [DOI] [PubMed] [Google Scholar]
  27. Rajaram S., Carlson S. E., Koo W. W., Rangachari A., Kelly D. P. Insulin-like growth factor (IGF)-I and IGF-binding protein 3 during the first year in term and preterm infants. Pediatr Res. 1995 May;37(5):581–585. doi: 10.1203/00006450-199505000-00004. [DOI] [PubMed] [Google Scholar]
  28. Reece E. A., Wiznitzer A., Le E., Homko C. J., Behrman H., Spencer E. M. The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors. Obstet Gynecol. 1994 Jul;84(1):88–95. [PubMed] [Google Scholar]
  29. Rosenfeld R. G., Rosenbloom A. L., Guevara-Aguirre J. Growth hormone (GH) insensitivity due to primary GH receptor deficiency. Endocr Rev. 1994 Jun;15(3):369–390. doi: 10.1210/edrv-15-3-369. [DOI] [PubMed] [Google Scholar]
  30. SECKEL H. P. Concepts relating the pituitary growth hormone to somatic growth of the normal child. AMA J Dis Child. 1960 Mar;99:349–379. doi: 10.1001/archpedi.1960.02070030351012. [DOI] [PubMed] [Google Scholar]
  31. Salardi S., Orsini L. F., Cacciari E., Righetti F., Donati S., Mandini M., Cicognani A., Bovicelli L. Growth hormone, insulin-like growth factor I, insulin and C-peptide during human fetal life: in-utero study. Clin Endocrinol (Oxf) 1991 Mar;34(3):187–190. doi: 10.1111/j.1365-2265.1991.tb00292.x. [DOI] [PubMed] [Google Scholar]
  32. Silbergeld A., Lazar L., Erster B., Keret R., Tepper R., Laron Z. Serum growth hormone binding protein activity in healthy neonates, children and young adults: correlation with age, height and weight. Clin Endocrinol (Oxf) 1989 Sep;31(3):295–303. doi: 10.1111/j.1365-2265.1989.tb01253.x. [DOI] [PubMed] [Google Scholar]
  33. Silverman B. L., Bettendorf M., Kaplan S. L., Grumbach M. M., Miller W. L. Regulation of growth hormone (GH) secretion by GH-releasing factor, somatostatin, and insulin-like growth factor I in ovine fetal and neonatal pituitary cells in vitro. Endocrinology. 1989 Jan;124(1):84–89. doi: 10.1210/endo-124-1-84. [DOI] [PubMed] [Google Scholar]
  34. Tapanainen P. J., Bang P., Wilson K., Unterman T. G., Vreman H. J., Rosenfeld R. G. Maternal hypoxia as a model for intrauterine growth retardation: effects on insulin-like growth factors and their binding proteins. Pediatr Res. 1994 Aug;36(2):152–158. doi: 10.1203/00006450-199408000-00004. [DOI] [PubMed] [Google Scholar]
  35. Woods K. A., Camacho-Hübner C., Savage M. O., Clark A. J. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med. 1996 Oct 31;335(18):1363–1367. doi: 10.1056/NEJM199610313351805. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood Fetal and Neonatal Edition are provided here courtesy of BMJ Publishing Group

RESOURCES